We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$27.8B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
-6.43%
1 Year Est. Return
+46.46%
3 Year Est. Return
+129.16%
5 Year Est. Return
+174.16%
10 Year Est. Return
+698%
AUM
$4.88B
AUM Growth
-$383M
(-7.3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
934
New
138
Increased
293
Reduced
289
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$40.2M |
| 2 |
Eli Lilly
LLY
|
+$37M |
| 3 |
PepsiCo
PEP
|
+$29.9M |
| 4 |
Wells Fargo
WFC
|
+$19M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$27.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$25.7M |
| 3 |
ExxonMobil
XOM
|
+$23.1M |
| 4 |
Costco
COST
|
+$22.1M |
| 5 |
Paychex
PAYX
|
+$18.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.97% |
| 2 | Healthcare | 17.42% |
| 3 | Technology | 17.02% |
| 4 | Industrials | 11.65% |
| 5 | Consumer Discretionary | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.67T
| $153M | 3.14% |
5,554,864
-244,696
| -4% | -$7.18M |
|
2
Amazon
AMZN
$2.79T
| $61.4M | 1.26% |
2,400,820
-61,400
| -2% | -$1.55M |
|
3
Gilead Sciences
GILD
$187B
| $61.3M | 1.26% |
623,823
-6,010
| -1% | -$667K |
|
4
Walt Disney
DIS
$182B
| $55.8M | 1.14% |
545,570
-21,480
| -4% | -$2.34M |
|
5
Amgen
AMGN
$236B
| $53.5M | 1.1% |
386,944
+554
| +0.1% | +$87.3K |
|
|
6
PepsiCo
PEP
$188B
| $52.4M | 1.08% |
556,102
+314,401
| +130% | +$29.9M |
|
7
Comcast
CMCSA
$94B
| $51.4M | 1.05% |
1,807,280
-105,080
| -5% | -$3.12M |
|
|
8
Wells Fargo
WFC
$272B
| $50.3M | 1.03% |
980,323
+345,730
| +54% | +$19M |
|
9
Merck
MRK
$371B
| $49M | 1% |
1,039,428
+45,871
| +5% | +$2.44M |
|
10
Visa
V
$700B
| $48.9M | 1% |
701,352
-67,750
| -9% | -$4.84M |
|
11
Boeing
BA
$168B
| $48.6M | 1% |
371,298
-3,482
| -0.9% | -$483K |
|
12
Bristol-Myers Squibb
BMY
$136B
| $47.7M | 0.98% |
806,448
+138,090
| +21% | +$8.76M |
|
13
Mastercard
MA
$507B
| $45.8M | 0.94% |
508,016
-35,210
| -6% | -$3.31M |
|
14
Kroger
KR
$35.9B
| $45.7M | 0.94% |
1,267,520
-84,960
| -6% | -$3.15M |
|
15
Pfizer
PFE
$162B
| $44.9M | 0.92% |
1,506,888
-104,799
| -7% | -$3.36M |
|
16
Intel
INTC
$506B
| $44.3M | 0.91% |
1,471,439
-194,590
| -12% | -$5.63M |
|
17
Verizon
VZ
$208B
| $42.6M | 0.87% |
979,645
-262,780
| -21% | -$12.1M |
|
18
UnitedHealth
UNH
$356B
| $41.8M | 0.86% |
360,634
+4,643
| +1% | +$556K |
|
|
EA
19
DELISTED
Electronic Arts
EA
| $41.6M | 0.85% |
614,188
-213,670
| -26% | -$15M |
|
|
20
Accenture
ACN
$114B
| $39.8M | 0.82% |
+404,880
| New | +$40.2M |
|
|
TWX
21
DELISTED
Time Warner Inc
TWX
| $38.1M | 0.78% |
553,690
+172,250
| +45% | +$13.5M |
|
|
22
Eli Lilly
LLY
$1.02T
| $37.4M | 0.77% |
446,768
+438,057
| +5,029% | +$37M |
|
23
McKesson
MCK
$106B
| $36.6M | 0.75% |
197,717
+2,582
| +1% | +$547K |
|
24
Cencora
COR
$63.2B
| $36.5M | 0.75% |
384,467
+14,000
| +4% | +$1.47M |
|
25
AbbVie
ABBV
$453B
| $36.4M | 0.75% |
669,534
+2,110
| +0.3% | +$137K |
|
Similar funds
UIM
SSA
CAM
CM
Jacobs Levy Equity Management's Q3 2015 Portfolio in Review
As of Q3 2015, Jacobs Levy Equity Management held 934 positions worth $4.88B, down 7.3% from $5.26B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q3 2015 filing shows 138 new, 293 increased, 289 reduced and 135 closed positions. Its largest new stake was Accenture: 404,880 shares worth $39.8M. The largest sale was Du Pont De Nemours E I, an estimated $27.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
- Jacobs Levy Equity Management's largest Q3 2015 buy was Accenture: 404,880 shares worth $39.8M.
- Jacobs Levy Equity Management added most to Eli Lilly in Q3 2015, an estimated $37M increase.
- Jacobs Levy Equity Management's biggest Q3 2015 reduction was Du Pont De Nemours E I, cutting an estimated $27.6M.
- Jacobs Levy Equity Management fully exited HEALTH NET INC in Q3 2015, selling an estimated $16M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.88B portfolio in Q3 2015.
- Jacobs Levy Equity Management opened 138 new positions and closed 135 in Q3 2015.
- Jacobs Levy Equity Management's portfolio value fell 7.3% quarter-over-quarter to $4.88B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2015, filed 16 Nov 2015.